Poland· PL-100406130
Megalotect CP
A cytomegalovirus immunoglobulin product containing cytomegalovirus immunoglobulinum humanum, registered in Poland by Biotest Pharma GmbH. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Cytomegalovirus immunoglobulin is registered in 9 of 19 countries.
Countries holding a registration under ATC J06BB09 (cytomegalovirus immunoglobulin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Cytomegalovirus immunoglobulin · ATC J06BB09
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Cytomegalovirus immunoglobulinum humanum
- Manufacturer
- Biotest Pharma GmbH
- Country
- Poland (PL)
- ATC code
- J06BB09
- ATC class
- Cytomegalovirus immunoglobulin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin04036124025465
- gtin04150069391789
- gtin04036124025472
- gtin04150069391840
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cytomegalovirus immunoglobulin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumIvegam-CMV 100 mg/mlCentrale Afdeling Voor Fractionering - Departement Central De Fractionnement
- United KingdomCytomegalovirus immunoglobulin human 3g powder for solution for infusion vialsScottish National Blood Transfusion Service
- GermanyCytotect CpBiotest Pharma Gmbh
- IrelandMegalotect 100 U/mL solution for infusionBiotest Pharma GmbH
- NetherlandsMegalotect 100 E/ml oplossing voor infusieBiotest Pharma GmbH
- SpainMEGALOTECT 100 U/ML SOLUCION PARA PERFUSIONBiotest Pharma Gmbh
- CanadaCYTOGAMKI BIOPHARMA LLC
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Cytotect Cp
- Belgium · Megalotect
- Czechia · Cymvigo
- Germany · Cytotect Cp
- Spain · Megalotect
- United Kingdom (Northern Ireland) · Cytotect Cp
- Greece · Megalotect Cp
- Croatia · Cytotect Cp
- Hungary · Cytotect Cp
- Ireland · Megalotect
- Italy · Cytomegatect
- Lithuania · Cymvigo
- Netherlands · Megalotect
- Portugal · Megalotect Cp
- Romania · Cytotect Cp
- Slovenia · Megalotect
- Slovakia · Cytotect
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6f664ae1-bcf4-4cbc-918e-1e6c1af38410 GET /v1/drugs/6f664ae1-bcf4-4cbc-918e-1e6c1af38410?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do infuzji",
"source": "urpl",
"strength": "100 U/ml",
"packaging": "04036124025465 ¦ Lz ¦ 130891\n1 fiol. 10 ml\n¦ UR/Z/4c/191/25 - 04150069391789 ¦ UR/Z/4c/241/25 - 04150069391789\n04036124025472 ¦ Lz ¦ 130892\n1 fiol. 50 ml\n¦ UR/Z/4c/285/25 - 04150069391840",
"substance": "Cytomegalovirus immunoglobulinum humanum 100 U/ml",
"common_name": "Cytomegalovirus immunoglobulinum humanum",
"pl_product_id": "100406130",
"pozwolenie_nr": "25708",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about cytomegalovirus immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.